AU7734496A - Alpha 1a adrenergic receptor antagonists - Google Patents

Alpha 1a adrenergic receptor antagonists

Info

Publication number
AU7734496A
AU7734496A AU77344/96A AU7734496A AU7734496A AU 7734496 A AU7734496 A AU 7734496A AU 77344/96 A AU77344/96 A AU 77344/96A AU 7734496 A AU7734496 A AU 7734496A AU 7734496 A AU7734496 A AU 7734496A
Authority
AU
Australia
Prior art keywords
alpha
receptor antagonists
adrenergic receptor
adrenergic
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77344/96A
Inventor
Mark G. Bock
Michael A. Patane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605165.1A external-priority patent/GB9605165D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU7734496A publication Critical patent/AU7734496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU77344/96A 1995-11-15 1996-11-12 Alpha 1a adrenergic receptor antagonists Abandoned AU7734496A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US796495P 1995-11-15 1995-11-15
US007964 1995-11-15
GBGB9605165.1A GB9605165D0 (en) 1996-03-12 1996-03-12 Alpha 1a adrenergic receptor antagonists
GB9605165 1996-03-12
PCT/US1996/018346 WO1997018209A1 (en) 1995-11-15 1996-11-12 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS

Publications (1)

Publication Number Publication Date
AU7734496A true AU7734496A (en) 1997-06-05

Family

ID=26308911

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77344/96A Abandoned AU7734496A (en) 1995-11-15 1996-11-12 Alpha 1a adrenergic receptor antagonists

Country Status (2)

Country Link
AU (1) AU7734496A (en)
WO (1) WO1997018209A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1014973A4 (en) * 1997-06-18 2000-09-20 Merck & Co Inc ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110449A (en) * 1977-05-23 1978-08-29 E. R. Squibb & Sons, Inc. 2-substituted benzisothiazol-3-ones
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
RU2118322C1 (en) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-dihydro-1,4-benzodioxine-5-yl-pyrerazine derivatives and salts thereof

Also Published As

Publication number Publication date
WO1997018209A1 (en) 1997-05-22

Similar Documents

Publication Publication Date Title
EP0822814A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
AU7692996A (en) Receptor antagonists
AU1345697A (en) Novel integrin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
AU5440996A (en) 2-acylaminopropanamides as tachykinin receptor antagonists
EP0998285A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
AU1765695A (en) Non-peptidyl tachykinin receptor antagonists
EP0833637A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST
AU4746297A (en) Vitronectin receptor antagonists
AU4803996A (en) Endothelin receptor antagonists
AU7694496A (en) Endothelin receptor antagonists
EP0831823A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
AU5196996A (en) Adhesion receptor antagonists
AU1230795A (en) Adhesion receptor antagonists
AU6856796A (en) Des-arg9-bk antagonists
EP0755392A4 (en) Alpha1c adrenergic receptor antagonists
AU1403099A (en) Alpha-1a adrenergic receptor antagonists
EP1019052A4 (en) Alpha 1a adrenergic receptor antagonists
EP1023068A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
AU3661895A (en) Adhesion receptor antagonists
AU6961796A (en) Improved interleukin-6 receptor antagonist
EP0831824A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
EP1014973A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
AU6060796A (en) Endothelin receptor antagonists
AU6646396A (en) Endothelin receptor antagonists